Jiang Xiaomeng: A Centennial Enterprise with Craftsman Spirit
Release time:
2020-07-31
Editor's Note: days ago, the United Front Work Department of Jinhua Municipal Committee, the Municipal Federation of Industry and Commerce and other units jointly launched a large-scale publicity campaign on "2016 Letter to Good Wu Merchants". 10# June 18 , Jinhua media reporters walked into the peak and made a collective interview with Chairman Jiang Xiaomeng. 10# October 21 , the front page of Jinhua Daily published the article "Jiang Xiaomeng: Strive for a Century of Enterprise with Craftsman Spirit" written by its reporter Zhang Shuai. This newspaper is reproduced.
58 , Chairman Jiang Xiaomeng's face is filled with passion and confidence.
58 years, the peak has experienced ups and downs. Every time it encounters a major turning point, generations of "peak people" have opened a new chapter with tireless efforts and simple wisdom.
11.03 .6 billion yuan, up 4.15% over the same period of last year; Net profit attributable to owners of the parent company reached 1.03 billion yuan, up 12.9 year on year. These data in the current weak domestic economic development, has become more prominent.
58 years, and are also the models of our "wushang" group to stick to industry, operate in good faith and serve the country by industry.
58 years ago, bearing in mind the history of the peak, can be seen at a glance by many old Jin Chinese. This is the original site of the Wisdom Temple in the north of Jinhua City. The place was small and desolate. The first group of pioneers built the first cement factory in Jinhua with their hands and blood.
20 years old, he walked into the gate of the cement factory and is now leading thousands of people to fight the business world. Jiang Xiaomeng said that this is the common growth and achievement of individuals and enterprises. 1993
28 , unusual for Jianfeng Group. On this day, Jianfeng stock started trading on the Shanghai Stock Exchange and became the country's first listed company in the cement industry, which laid the foundation for the standardized management and further development of Jianfeng Group. to 2006
2007 , the cement market competition is extremely fierce, coupled with the state's policy restrictions on the closure of mechanical vertical kilns, many cement plants have lost their competitiveness. Spikes are also facing harsh realities, and benefits are plummeting. At this key node, Jianfeng cooperated with central enterprises in a timely manner to transfer the equity of cement enterprise 65% in Zhejiang Province, set up Southern Cement, became one of the sponsors of Southern Cement, and invested limited funds in the central and western regions with more advantages in market prospects, resources and supply. After the most difficult period from 2006 to
, Jianfeng promptly established the development policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development", and became an industrial pattern with cement and medicine as the two main businesses, bonded logistics as the supplement, and multiple investments in concentric related industries as the supplement, which further clarified the industrial positioning of the group, be a niche in the cement market, a leader in the pharmaceutical industry segment, and a leader in health product innovation. Jiang Xiaomeng said that these decisions are strategic choices made in combination with the actual situation of the peak and the development trend, and are the self-adjustment of the peak group on the road of development. Only when the positioning is accurate and the goal is clear can an enterprise have the driving force for sustainable development.
Looking forward to the future, driven by innovation in medicine and health, the industry is booming
. Besides complementing cement and having a broad market, Jiang Xiaomeng hopes to stimulate the vitality of the peak through medicine and health.
During the peak years of
, Jiang Xiaomeng knew very well that innovation and development are the best catalysts for enterprises to maintain vitality. To be brave, transformation and upgrading are the best driving forces. The medical and health industry is also one of the most obvious industries driven by scientific and technological innovation. Jianfeng Pharmaceutical has always paid attention to the innovative research and development of pharmaceutical products. It has two professional research institutions and a provincial new drug research and development center. At the same time, it has
academician expert workstations and 3 postdoctoral mobile stations in the field of plant extracts and chemical pharmaceuticals respectively, and has obtained more than 20 national invention patents . This has laid a solid foundation for the innovation of peak pharmaceutical products. Many products of Jianfeng Pharmaceutical have been listed as national high-tech industrialization demonstration project, national key new product plan project and national torch plan project, and have been rated as national high-tech enterprises for 10 years in a row. In addition, with the deepening of the management of pharmaceutical commercial circulation order, the peak will effectively integrate the existing internal circulation enterprises in the field of circulation, and constantly improve the profitability and business model with innovative thinking, so as to make the pharmaceutical circulation enterprises more standardized, more orderly and stronger, and further enhance their competitiveness. Jianfeng Health Technology Co., Ltd. is another major layout of Jianfeng Group in the field of health in recent years. Entering the company's laboratory, high-tech experimental equipment can be seen everywhere. In front of a piece of equipment, Yu Hongjian, general manager of the Health Technology Company, told reporters that this is the first production equipment used in ginkgo extract in China. The entire production process is operated and monitored in real time by the computer system in the central control room to minimize Human errors and risks ensure stable and safe product quality. In the central control room, the reporter also saw two staff members staring at the large computer screen all the time, paying attention to the changes in the monitoring values on the screen.
In the Peak Health Experience Hall, Jiang Xiaomeng introduced that the big health industry is a very broad concept, including health care products, health care for the aged, health care, etc. With the improvement of people's living conditions, people's demand will be more and more big. The human demand for health, health care and longevity is an irreversible trend and trend. The positioning of the peak for the big health industry is: natural raw materials, ancient and modern use, changing tradition into fashion, and being a leader in health product innovation. Around this concept, Spike has done a lot of work in innovative decoction pieces and has obtained a number of patents, for example, many people know that eating Gastrodia elata is good, but the texture of Gastrodia elata is hard, how to eat it? Spike Health makes Gastrodia elata slices that dehydrate and freeze-dry slices of fresh Gastrodia elata, which is as simple and convenient as eating potato chips. There are also freeze-dried ultra-fine powder of noto-ginseng, freeze-dried Dendrobium, heart-shaped Astragalus tablets and so on.
listed
years, Jianfeng Group's total assets have increased from 1.38 .2 billion yuan at the beginning of listing to 35.78 .4 billion yuan now, and its net assets have increased from less than 1 .6 billion yuan to 22.01 .8 billion yuan, increasing nearly 26 times and 22 times respectively. operates in good faith, sticks to industry, and does not forget social responsibility
In the Jianfeng History Showroom, photos with historical accumulation make people feel that Jianfeng Group is working hard and at the same time, they also see Jianfeng's active social responsibility. Since the listing of
, the peak tax payment and social security payment have exceeded
.3 billion yuan, which has been a major taxpayer of enterprises in Jinhua for many years. Jianfeng Group, Jianfeng Pharmaceutical, Jianfeng Cement and other holding companies were rated as Zhejiang Province 3A -class contract-abiding and trustworthy units, integrity management enterprises. Jianfeng Group has just won the silver award of "Zhejiang Industry Award" in 2016 this year, and is the second batch of "three" cultivation pilot enterprises in Zhejiang Province. Jianfeng Group has also carried out fruitful work in enterprise pairing, thousand enterprise pairing, and employee labor security. It has been rated as an advanced ideological and political work unit in Zhejiang Province and Jinhua City for many years. started from
April with a donation of of 20 .56 million yuan to build "Zhejiang Jianfeng Hope Primary School" (the first Hope Primary School on the "Roof of the World" aided by an enterprise) in Nagqu District of Tibet Autonomous Region. Jianfeng Group's "Hope" road lasted for 21 years. In the meantime, 8 Hope Primary School, which was built with high-end donations, has sprung up. Its donation areas cover Tibet, Gansu, Yunnan and our Jinhua region.
.5 billion yuan in environmental protection technological transformation funds exceeding . Because ecological development has been implanted into corporate culture, many important activities can always see the figure of the peak, such as Jinhua five water co-governance, Wenchuan earthquake relief, Jinhua Red Cross donation AED automatic defibrillator and so on.
58 years, in addition to the upbringing of Jinhua, is also because the peak development has four cornerstones: a strong corporate culture, a development path suitable for itself, and an endogenous expansion desire that matches its own strength, there is a management team that highly identifies with the culture of spikes. "Our mission is to be a century-old peak, and generations of peak people will dream of the future with the spirit of craftsmen." ("Jinhua Daily" reporter Zhang Shuai)
More information
Yunnan peak through the safety standard secondary acceptance
On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate
2020
07-30
Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory
News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Accident-free factory creation enters "second season"
At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open
2020
07-31
What will the Chinese Medicine Act bring us?
At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page